Extrapulmonary manifestation in sarcoidosis can present with multifocal neurological and psychiatric symptoms, multifocal MRI pathology (including leptomeningeal involvement), hearing loss ...

scan in non-neurosarcoidosis, cardiac PET/cardiac magnetic resonance imaging (cMRI) in CS or brain MRI changes suggestive of edema/inflammation in neurosarcoidosis (97–102); (b) demonstration of ...

Indeed, during sarcoidosis, spinal cord enhancement may persist for over 6 months and take a year or longer to disappear completely (2). A case series reported that during the acute phase spinal cord ...

sarcoid, amyloidosis and many others) and adaptive (athleticism). On the basis of mainly their imaging phenotype, the genetic cardiomyopathies are typically subdivided into five characteristic ...

She emphasized the importance of consistently using the PRIMARY score to grade prostatic lesions, in order to avoid the pitfalls of false positive readings, with this classification system been shown ...

aDepartment of Neurology, St Mary’s Hospital, Praed Street, London, UK, bNational Hospital for Neurology and Neurosurgery, Queen Square, London, UK Dr Larner, National Hospital for Neurology and ...

Today, manager Terry Francona tells Sheldon that the backstop is headed for an MRI. “He’s going to be fine,” Francona said yesterday. “It just didn’t seem to make sense to push something ...

After working on AI-powered tools to enhance X-rays and mammographies, French startup Gleamer now aims to tackle magnetic resonance imaging (MRI). Gleamer is part of the second wave of startups ...

Sex differences in the risk factors, diagnosis, treatment, and outcomes of patients with cardiovascular disease have been ...

Allen is expected to undergo an MRI on Saturday, an off day for the team. The Cavs, who improved to a league-best 46-10 with their most-lopsided win ever over New York, host the Memphis Grizzlies ...

Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025. Fourth positive DSMB review for efzofitimod in Phase 3 EFZO-FIT™ study ...